Symbol="CRVS"
AssetType="Common Stock"
Name="Corvus Pharmaceuticals Inc"
Description="Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. The company is headquartered in Burlingame, California."
CIK="1626971"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="863 MITTEN ROAD, SUITE 102, BURLINGAME, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="101359000"
EBITDA="-29703000"
PERatio="None"
PEGRatio="0"
BookValue="1.012"
DividendPerShare="0"
DividendYield="0"
EPS="-0.76"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.249"
ReturnOnEquityTTM="-0.601"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.76"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6.9"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.576"
EVToRevenue="-"
EVToEBITDA="0.265"
Beta="0.975"
num_52WeekHigh="4.19"
num_52WeekLow="0.607"
num_50DayMovingAverage="2.326"
num_200DayMovingAverage="1.508"
SharesOutstanding="48965900"
DividendDate="None"
ExDividendDate="None"
symbol="CRVS"
open="2.10"
high="2.15"
low="2.04"
price="2.07"
volume="137843.00"
latest_trading_day="2023-08-25"
previous_close="2.10"
change="-0.03"
change_percent="-1.1933%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="12"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="88"
Volume_recent_avg="816798"
Change_recent_avg="-0.01"
Delta_recent_avg="0.26"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-0.33"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="88"
Aroon_momentum_negative="12"
image_negative_thumbnail_id_1="502"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0103.jpeg"
image_negative_thumbnail_id_2="1150"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0183.jpeg"
image_neutral_thumbnail_id_1="580"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="579"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0020.jpeg"
image_positive_thumbnail_id_1="631"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0077.jpeg"
image_positive_thumbnail_id_2="662"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
